786 related articles for article (PubMed ID: 17197367)
1. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.
Mehler-Wex C; Riederer P; Gerlach M
Neurotox Res; 2006 Dec; 10(3-4):167-79. PubMed ID: 17197367
[TBL] [Abstract][Full Text] [Related]
2. Dopamine and the regulation of cognition and attention.
Nieoullon A
Prog Neurobiol; 2002 May; 67(1):53-83. PubMed ID: 12126656
[TBL] [Abstract][Full Text] [Related]
3. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
Prince J
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
[TBL] [Abstract][Full Text] [Related]
4. [Changes in neural networks by conditional transgenic approach: a key to our comprehension of neuro-psychiatric disorders in the basal ganglia system].
Schiffmann SN
Bull Mem Acad R Med Belg; 2009; 164(7-9):171-8; discussion 178-80. PubMed ID: 20218186
[TBL] [Abstract][Full Text] [Related]
5. Striatal sensitivity during reward processing in attention-deficit/hyperactivity disorder.
Paloyelis Y; Mehta MA; Faraone SV; Asherson P; Kuntsi J
J Am Acad Child Adolesc Psychiatry; 2012 Jul; 51(7):722-732.e9. PubMed ID: 22721595
[TBL] [Abstract][Full Text] [Related]
6. A comparison of phenylketonuria with attention deficit hyperactivity disorder: do markedly different aetiologies deliver common phenotypes?
Stevenson M; McNaughton N
Brain Res Bull; 2013 Oct; 99():63-83. PubMed ID: 24140048
[TBL] [Abstract][Full Text] [Related]
7. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
[TBL] [Abstract][Full Text] [Related]
8. Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder.
Cheon KA; Ryu YH; Kim YK; Namkoong K; Kim CH; Lee JD
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):306-11. PubMed ID: 12552351
[TBL] [Abstract][Full Text] [Related]
9. Attention deficit/hyperactivity disorder: is there a correlation between dopamine transporter density and cerebral blood flow?
da Silva N; Szobot CM; Anselmi CE; Jackowski AP; Chi SM; Hoexter MQ; Anselmi OE; Pechansky F; Bressan RA; Rohde LA
Clin Nucl Med; 2011 Aug; 36(8):656-60. PubMed ID: 21716015
[TBL] [Abstract][Full Text] [Related]
10. Chapter 33: the history of movement disorders.
Lanska DJ
Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
[TBL] [Abstract][Full Text] [Related]
11. Basal ganglia, movement disorders and deep brain stimulation: advances made through non-human primate research.
Wichmann T; Bergman H; DeLong MR
J Neural Transm (Vienna); 2018 Mar; 125(3):419-430. PubMed ID: 28601961
[TBL] [Abstract][Full Text] [Related]
12. [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].
Emond V; Joyal C; Poissant H
Encephale; 2009 Apr; 35(2):107-14. PubMed ID: 19393378
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorder.
Curtin K; Fleckenstein AE; Keeshin BR; Yurgelun-Todd DA; Renshaw PF; Smith KR; Hanson GR
Neuropsychopharmacology; 2018 Dec; 43(13):2548-2555. PubMed ID: 30209407
[TBL] [Abstract][Full Text] [Related]
14. Schizophrenia and Parkinson's disease lead to equal motor-related changes in cortical and subcortical brain activation: an fMRI fingertapping study.
Müller JL; Deuticke C; Putzhammer A; Röder CH; Hajak G; Winkler J
Psychiatry Clin Neurosci; 2003 Dec; 57(6):562-8. PubMed ID: 14629703
[TBL] [Abstract][Full Text] [Related]
15. In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.
Nikolaus S; Antke C; Müller HW
Behav Brain Res; 2009 Dec; 204(1):32-66. PubMed ID: 19523495
[TBL] [Abstract][Full Text] [Related]
16. [Neurotransmission in developmental disorders].
Takeuchi Y
No To Hattatsu; 2008 Nov; 40(6):451-5. PubMed ID: 19039985
[TBL] [Abstract][Full Text] [Related]
17. [Alterations in the pattern of dopaminergic markers in attention-deficit/hyperactivity disorder].
Díaz-Heijtz R; Mulas F; Forssberg H
Rev Neurol; 2006 Feb; 42 Suppl 2():S19-23. PubMed ID: 16555214
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back.
Bergman H; Deuschl G
Mov Disord; 2002; 17 Suppl 3():S28-40. PubMed ID: 11948753
[TBL] [Abstract][Full Text] [Related]
19. Association of Parkinson's disease with symptoms of attention deficit hyperactivity disorder in childhood.
Walitza S; Melfsen S; Herhaus G; Scheuerpflug P; Warnke A; Müller T; Lange KW; Gerlach M
J Neural Transm Suppl; 2007; (72):311-5. PubMed ID: 17982908
[TBL] [Abstract][Full Text] [Related]
20. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
